Age and molecular subtypes: impact on surgical decisions

Area of Science:

• Oncology
• Surgical Oncology
• Genomics

Background:

• Local recurrence in breast cancer is influenced by patient age and tumor biology.
• Younger patients and specific molecular subtypes (e.g., triple-negative, HER2-enriched) often present with higher-risk disease.
• Understanding these factors is crucial for optimizing treatment strategies and patient outcomes.

Purpose of the Study:

• To investigate the impact of patient age and breast cancer molecular subtypes on local recurrence rates.
• To determine if more extensive surgical interventions mitigate the elevated recurrence risk associated with young age and high-risk subtypes.
• To analyze the long-term prognosis in relation to these clinical and biological factors.

Main Methods:

• Retrospective analysis of breast cancer patient data.
• Stratification of patients based on age (young vs. older) and molecular subtype (e.g., Luminal A, Luminal B, HER2-enriched, triple-negative).
• Comparison of local recurrence rates and survival outcomes between different patient groups and surgical approaches.

Main Results:

• Younger patient age was associated with significantly higher rates of local breast cancer recurrence.
• High-risk molecular subtypes also demonstrated a clear trend towards increased local recurrence.
• The benefit of more extensive surgery in overcoming the heightened recurrence risk in young or high-risk subtype patients was not evident.

Conclusions:

• Patient age and molecular subtype are critical determinants of local recurrence risk in breast cancer.
• Current surgical approaches may not sufficiently address the intrinsic risk posed by younger age and aggressive tumor biology.
• Further research into systemic therapies and novel surgical techniques is warranted for high-risk breast cancer populations.